AI is about to change healthcare. These 30 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.
To be a shareholder in Albemarle, you need conviction in the global growth of lithium demand, particularly from electric vehicles and energy storage, outweighing near-term volatility in lithium prices. The latest news, while showing share price gains and improved financials, does not materially change the immediate catalyst: a sustained rebound in lithium pricing, nor the main risk of prolonged market oversupply and continued price weakness.
Among recent corporate actions, Albemarle reaffirmed its 2025 net sales guidance of US$4.9 billion to US$5.2 billion. This announcement is meaningful amid shifting lithium prices, as it underscores Albemarle’s confidence in its revenue outlook and provides investors with a benchmark against which to gauge the impact of volatile market conditions.
On the other hand, investors should be aware of persistent lithium oversupply and its potential to further compress margins and …
Read the full narrative on Albemarle (it's free!)
Albemarle's outlook calls for $6.9 billion in revenue and $1.1 billion in earnings by 2028. This is based on analysts assuming 11.5% annual revenue growth and an increase in earnings of $2.2 billion from the current -$1.1 billion.
Uncover how Albemarle's forecasts yield a $103.01 fair value, a 12% downside to its current price.
Ten different Simply Wall St Community fair value estimates range from US$88.90 to US$143.88, reflecting varied views on Albemarle's future. With ongoing lithium price swings impacting margins, explore other perspectives below.
Explore 10 other fair value estimates on Albemarle - why the stock might be worth as much as 23% more than the current price!
Disagree with existing narratives? Create your own in under 3 minutes - extraordinary investment returns rarely come from following the herd.
Early movers are already taking notice. See the stocks they're targeting before they've flown the coop:
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com